RFA-PS-18-000 | RFA PS 18 000

Opportunity Information: Apply for RFA PS 18 000

RFA-PS-18-000 is a discretionary federal funding opportunity from the U.S. Department of Health and Human Services, administered by the Centers for Disease Control and Prevention (CDC) through ERA. The award mechanism is a cooperative agreement, which generally means recipients should expect substantial involvement from CDC staff during project implementation (for example, collaboration on program strategy, reporting, evaluation approaches, or technical guidance), rather than operating with the more hands-off relationship typical of a standard grant. The program sits in the Health funding activity category and is associated with CFDA number 93.136.

This listing is structured as a broad, ongoing opportunity that primarily serves as a submission vehicle for a specific application type. The description indicates applicants should "submit application as necessary for Type 6 Applications," which suggests the announcement is intended for a particular administrative or continuation action category defined by the agency. In practice, this kind of language often points to submissions that are not traditional open, competitive new applications, but instead are made when a recipient is instructed or otherwise authorized to submit under that application type. Because the notice does not include project scope, required activities, or review criteria in the provided text, the key takeaway is that the announcement functions more like an administrative gateway for authorized Type 6 submissions than a fully described program competition.

Eligibility is listed as "Others," with the note that clarification is provided in an "Additional Information on Eligibility" field. That implies eligibility may be limited to certain organizations, possibly including specific categories of institutions or entities named in the full announcement text. Without that additional eligibility language, it is not possible to reliably narrow who can apply beyond what is stated here, but the presence of a specialized application type and the "Others" designation can indicate the applicant pool may be restricted or situational.

The record shows a creation date of October 20, 2023, and an original closing date of October 13, 2025, indicating a relatively long window during which submissions may be accepted, as needed, for Type 6 actions. The listing also notes an expected number of awards of 100. The award ceiling is displayed as 0, which typically means the ceiling is either not specified in this summary record, is determined by other controlling documents, or varies by applicant/action rather than being set at a single maximum amount within the listing.

Overall, RFA-PS-18-000 is best understood as a CDC cooperative agreement opportunity tied to CFDA 93.136, open through October 2025, designed to accept Type 6 applications when appropriate, with eligibility defined in the full opportunity text rather than in the brief summary fields provided.

• The Department of Health and Human Services, Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "RFA-PS-18-000" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.136.
• This funding opportunity was created on Oct 20, 2023.
• Applicants must submit their applications by Oct 13, 2025. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 100 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for RFA PS 18 000

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: